Abstract:Abstract Animal models of erythropoiesis related genes have been limited by the fact that some of these genes have non-erythroid expression and other functions in addition to erythropoiesis and thus their knock-out may be embryonic lethal. Tissue specific knock-out or knock-in mice models employing GATA-1-Cre and other constructs showed that these promoters are also active in non-hematopoietic tissues, i.e. GATA-1 has activity in early embryonic development and in neuronal tissue. Suzuki et al (Blood, 2002, 100; 2279) isolated the GATA-1 locus hematopoietic regulatory domain (GATA-1-HRD) and demonstrated that the expression of a transgene under its control is limited to the hematopoietic tissue. We generated a transgenic mouse expressing an improved Cre (iCre) under GATA-1-HRD promoter control. This mouse was crossbred with ROSA 26 mouse and the progeny was examined for tissue specificity of iCre expression using beta-galactosidase staining. Brain, spleen, kidney, heart, thymus, liver, lung and ovary were examined for whole organ LacZ staining. All tested organs were negative except kidney and spleen where some positivity was observed. Subsequently, we prepared tissue sections from kidney, spleen and bone marrow and stained with LacZ and anti-beta-galactosidase antibody. Only the bone marrow EpoR expressing cells were positive; the kidney and the spleen cells were negative. Although Suzuki et al previously showed expression of the GATA-1-HRD driven erythropoietin receptor in spleen using RT-PCR, we were not able to find iCre expression in the splenic cells using these approaches. We demonstrate that our transgenic mouse (GATA-1-HRD-iCre) showed a restricted iCre expression in hematopoietic tissue that differs from previous studies of other hematopoiesis specific cre mouse. We conclude that this mouse model should be useful in studies of function of erythroid specific genes.

Expression of Cre Recombinase in an Enhancer-Cre Transgenic Mouse

The Construction of a Cre Recombinase Expression Vector That Targets the Expression of Cre in Pancreas of Transgenic Mouse

Functional Assessment of Expression of Cre Recombinase Targeting the Liver of Transgenic Mice Regulated by Tet-on and Cre/loxP System

Stable Transgenic Mouse Strain with Enhanced Photoactivatable Cre Recombinase for Spatiotemporal Genome Manipulation

Transgenic mice with hematopoietic and lymphoid specific expression of Cre

Construction and Tissue Specific Expression of Cre Transgenic Mice

Transgenic mouse model exhibiting weak red fluorescence before and strong green fluorescenceafter Cre/loxP-mediated recombination

Generation and Characterization of Transgenic Mice Expressing Tamoxifen-Inducible Cre-Fusion Protein Specifically in Mouse Liver.

Conditional gene targeting in mouse high endothelial venules

Cre Reconstitution Allows for Dna Recombination Selectively in Dual-Marker-Expressing Cells in Transgenic Mice

Emx1-Specific Expression of Foreign Genes Using “Knock-In” Approach

CRISPR/Cas9-mediated targeting of the Rosa26 locus produces Cre reporter rat strains for monitoring Cre/loxP-mediated lineage tracing.

A robust and high-throughput Cre reporting and characterization system for the whole mouse brain

Generation of a Transgenic Mouse Model with Chondrocyte-Specific and Tamoxifen-Inducible Expression of Cre Recombinase.

Construction of Afp-cre-lacZ Transgenic Mouse Model

Inner hair cell Cre-expressing transgenic mouse.

Transgenic Mice That Express Cre Recombinasein Hypertrophic Chondrocytes

Hematopoietic Specific GATA-1-Improved Cre Mouse for Erythroid-Specific Gene Modification.

A Transgenic Cre Mouse Line for the Study of Cortical and Hippocampal Development

Production of a Reporter Transgenic Pig for Monitoring Cre Recombinase Activity.

Comparative Study on the Expression Characteristics of Transgenes Inserted into the Gt(ROSA)26Sor and H11 Loci in Mice.